Traditional and MLC based dose compensator design for patients with hip prostheses undergoing pelvic radiation therapy.
Perturbations in the dose distribution caused by a hip prosthesis when treating pelvic malignancies can result in unacceptable dose inhomogeneities within the target volume. Our results, obtained by in vivo exit dose measurements with diodes, showed a 55% reduction in the dose at the exit dmax of a lateral 15 MV photon beam after passing through a bilateral cobalt-chrome alloy hip prosthesis. Such an inhomogeneous dose distribution may decrease the curability. Solutions such as treatment techniques to avoid the prosthesis are often not the best choice as the dose to the rectum may be unacceptably high. In this work an alternative method of dose compensator is presented. Two types of dose compensators were designed based on a 3-D treatment planning system and CT images of a pelvic phantom containing a hip prosthesis: one was fabricated from a polyethylene-lead slab in the representation of step fringes and placed on a tray in the path of the beam while the other was produced by the use of several fields shaped with a multileaf collimator. The calculation procedures developed by the authors for generating the compensators are described. Results of film measurements performed in a phantom with and without the compensators in place are discussed.
Alecu
R
R
Physician Reliance Network & Texas Oncology, P.A., Texas Cancer Center, Sherman 75090, USA.
Alecu
M
M
Loomis
T
T
Ochran
T
T
He
T
T
D000497:Alloys; D019644:Arthroplasty, Replacement, Hip; D002858:Chromium Alloys; D006801:Humans; D010386:Pelvic Neoplasms / Q000532:radiotherapy*; D010388:Pelvis / Q000000981:diagnostic imaging; D019047:Phantoms, Imaging; D011878:Radiotherapy / Q000379:methods; D011879:Radiotherapy Dosage; D014025:Titanium; D014057:Tomography, X-Ray Computed
D000497:Alloys; D002858:Chromium Alloys; D014025:Titanium